About Holoclara
We develop novel therapeutics derived from symbiotic organisms that modulate inflammation, metabolism, and tissue regeneration- core pathways that underlie chronic disease, resilience, and aging.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
holoclara.com
Domain Registered Date
Jan 23, 2017
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $16,000,000 · Series-A
fundraisingfox.com
- Milestone
X account created (@Holoclara_Inc)
26 followers
- Milestone
Website domain registered
holoclara.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Holoclara.
Funding History
Series-A
· Jun 27, 2024
$16,000,000 fundraisingfox.com
Founders & Leadership
Andrea Choe
CEO / CO-FOUNDER
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026